Human papillomavirus–associated oropharyngeal cancer: review of current evidence and management

EL You, M Henry, AG Zeitouni - Current Oncology, 2019 - mdpi.com
Oropharyngeal cancer (OPC) has become the leading site for human papillomavirus (HPV)–
associated cancers in humans. It is an epidemic that remains relatively unfamiliar to most …

Dysphagia treatment for patients with head and neck cancer undergoing radiation therapy: a meta-analysis review

E Greco, T Simic, J Ringash, G Tomlinson… - International Journal of …, 2018 - Elsevier
Purpose Patients undergoing radiation therapy with or without chemotherapy (C/RT) for
head and neck cancer (HNC) often develop dysphagia. Interventions from speech-language …

[HTML][HTML] Treatment de-escalation for HPV-associated oropharyngeal squamous cell carcinoma with radiotherapy vs. trans-oral surgery (ORATOR2): study protocol for …

AC Nichols, P Lang, E Prisman, E Berthelet, E Tran… - BMC cancer, 2020 - Springer
Background Patients with human papillomavirus-positive (HPV+) oropharyngeal squamous
cell carcinoma (OPC) have substantially better treatment response and overall survival (OS) …

Clinical variables and magnetic resonance imaging‐based radiomics predict human papillomavirus status of oropharyngeal cancer

P Bos, MWM van den Brekel, ZAR Gouw… - Head & …, 2021 - Wiley Online Library
Background Human papillomavirus (HPV)‐positive oropharyngeal squamous cell
carcinoma (OPSCC) have better prognosis and treatment response compared to HPV …

Treatment outcomes and survival following definitive (chemo) radiotherapy in HPV‐positive oropharynx cancer: Large‐scale comparison of DAHANCA vs PMH …

P Lassen, SH Huang, J Su, J Waldron… - … Journal of Cancer, 2022 - Wiley Online Library
We compare outcomes in two large‐scale contemporaneously treated HPV‐positive (HPV+)
oropharynx cancer (OPC) cohorts treated with definitive radiotherapy/chemoradiotherapy …

[HTML][HTML] Recent research on combination of radiotherapy with targeted therapy or immunotherapy in head and neck squamous cell carcinoma: a review for radiation …

DT Xing, R Khor, H Gan, M Wada, T Ermongkonchai… - Cancers, 2021 - mdpi.com
Simple Summary Radiotherapy (RT) is an effective treatment for head and neck squamous
cell carcinoma (HNSCC). Concurrent RT with high dose cisplatin (100 mg/m2, days 1, 22 …

[HTML][HTML] Background paper for the recommendation of HPV vaccination for boys in Germany

A Takla, M Wiese-Posselt, T Harder… - Bundesgesundheitsblatt …, 2018 - Springer
Infections with human papillomaviruses (HPVs) are common among women and men [2].
HPV infections are thought to be among the most common sexually transmitted infections …

Epidemiology and patient distribution of oral cavity and oropharyngeal SCC in Canada

FM Ghazawi, J Lu, E Savin, A Zubarev… - Journal of …, 2020 - journals.sagepub.com
Background Oral cavity cancers (OCCs) and oropharyngeal cancers (OPCs) continue to be
a major source of morbidity and mortality worldwide requiring the shared effort of numerous …

[HTML][HTML] An occult HPV-driven oropharyngeal squamous cell carcinoma discovered through a saliva test

KD Tang, S Vasani, T Taheri, LJ Walsh… - Frontiers in …, 2020 - frontiersin.org
Oropharyngeal cancer (OPC) caused by human papillomavirus (HPV) is a rising global
concern. Early lesions are small and are often located in difficult to access areas (such as …

Evidence for different molecular parameters in head and neck squamous cell carcinoma of nonsmokers and nondrinkers: Systematic review and meta‐analysis on …

FJ Mulder, DDCG Pierssens, LWJ Baijens… - Head & …, 2021 - Wiley Online Library
Background The goal of this review was to present an overview of the currently identified
molecular parameters in head and neck squamous cell carcinoma (HNSCC) of nonsmokers …